Skip to content

Magnetic resonance (MR) angiography with a blood pool contrast medium.

Magnetic resonance (MR) angiography with a blood pool contrast medium.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2007-002730-11-GB
Enrollment
Unknown
Registered
2007-07-31
Start date
2007-11-30
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abnormalities of the major venous system. MedDRA version: 9.1 Level: LLT Classification code 10047184 Term: Vein disorder

Interventions

Sponsors

Cambridge University Hospitals NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients over 18 years of age who have been routinely referred for an MR angiography examination to assess the major thoraco-abdominal veins (including in the neck) in respect of venous access. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: The presence of any of the following will preclude patient inclusion: - Age of the patient under 18 years. - Contraindication to MRI (eg. Pacemaker, aneurysm clips, orbital metal) - Contraindication to intravenous gadolinium agents (eg. Contrast medium allergy). In Addenbrooke’s Hospital, this includes patients with liver transplants and patients with impaired renal function (GFR of less than 60 ml/min/1.73 m2) - Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Primary end point(s): After completion of 30 MR angiography studies assessing the venous system.;Main Objective: To assess image quality in terms of vessel conspicuity using a five-point scale - excellent (optimal visualisation of the vessel with no signal loss), good (slight signal loss but good overall visualisation of the vessel), moderate (decreased signal intensity but images remain diagnostic), poor (insufficient signal intensity such that the vessel is not completely identifiable and the image is not diagnostic, or very poor (no or hardly any signal intensity and the vessel cannot be identified).;Secondary Objective: To assess for stenosis using a six-point scale – no (0%) stenosis, mild (1-30%) stenosis, mild-to-moderate (31-50%) stenosis, moderate (51-75%) stenosis, severe (76-99%) stenosis, or total vessel occlusion. To assess for additional thrombosis using a three-point scale – no thrombosis, partial thrombosis, complete thrombosis. To assess for the presence of artifacts as rated by a three-point scale – none, mild (artifacts present but not impairing diagnostic information), or major (extensive artifacts impair diagnosis).

Countries

United Kingdom

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026